-+ 0.00%
-+ 0.00%
-+ 0.00%

Xilio Therapeutics director Cheryl R. Blanchard files initial beneficial ownership statement

PUBT·04/16/2026 21:11:58
Listen to the news
Xilio Therapeutics director Cheryl R. Blanchard files initial beneficial ownership statement
  • Xilio Therapeutics filed an initial beneficial ownership statement naming Cheryl R. Blanchard as a director, dated April 15.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-159314), on April 16, 2026, and is solely responsible for the information contained therein.